| PRIMARY INFORMATION |
|---|
| ID | 1344 |
| PMID | 2054872 |
| Year | 1991 |
| Sequence | SNLST-Asu-VLGKLSQEL
HKLQTYPRTDVGAGTP |
| Name | Elcatonin |
| Length | 31 |
| N-Terminal Modification | Free |
| C-Terminal Modification | Amidation |
| Linear/ Cyclic | Cyclic (bond between Ser1 and Asu6) |
| Chirality | L |
| Chemical Modification | Asu=Aminosuberic Acid |
| Origin of Peptide | Synthetic analogue of eel calcitonin in which disulfide bridge between first and seventh amino acids is replaced by -CH2CH2- bridge |
| Nature of Peptide/Cargo | It stimulates osteoblastic bone formation in addition to inhibiting osteoclastic bone resorption |
| Mechanism | Not mentioned |
| Cargo Sequence/Structure | None |
Name of cargo
| Not applicable |
| Assay | o-cresolphthalein complexone method using Calcium C-Test Wako and 0.01 ml plasma, pharmacokinetic and statistical analysis |
| Enhancer | n-octyl-β-D-thioglucoside=1.5g, Taurocholate=1g |
| Properties of enhancer | Not mentioned |
| Concentration | Glycerin-93.1g, Hiviswako 104-1g, Elcatonin-25.0mg, Triethanolamine-1.37g, Gentamycin sol.-2.0g and enhancers |
| Incubation time | 24 Hours |
| Tissue permeability (value with units) | Area under the curve(mg.h/dl)=35.23±33.53 , Area under the first moment curve(mg.h2/dl)=490.35±444.31 , The mean residence time(h)=16.31±6.88 , Apparent bioavailability(%)=3.04. |
| Tissue Sample | Stratum corneum of the abdominal area of male Wistar rats(0.5g ointment/4 cm2/rat) |
| Ex vivo/In vivo/In vitro | in vivo |
| SECONDARY INFORMATION |
|---|
| STRUCTURE | |
| SMILES | N.A. |
